↓ Skip to main content

Cochrane Database of Systematic Reviews

Cannabis and schizophrenia

Overview of attention for article published in Cochrane database of systematic reviews, October 2014
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news
5 news outlets
blogs
2 blogs
policy
1 policy source
twitter
53 tweeters
facebook
1 Facebook page
wikipedia
2 Wikipedia pages
googleplus
2 Google+ users

Citations

dimensions_citation
51 Dimensions

Readers on

mendeley
329 Mendeley
Title
Cannabis and schizophrenia
Published in
Cochrane database of systematic reviews, October 2014
DOI 10.1002/14651858.cd004837.pub3
Pubmed ID
Authors

Benjamin C McLoughlin, Jonathan A Pushpa-Rajah, Donna Gillies, John Rathbone, Hannele Variend, Eliana Kalakouti, Katerina Kyprianou

Abstract

Schizophrenia is a mental illness causing disordered beliefs, ideas and sensations. Many people with schizophrenia smoke cannabis, and it is unclear why a large proportion do so and if the effects are harmful or beneficial. It is also unclear what the best method is to allow people with schizophrenia to alter their cannabis intake.

Twitter Demographics

The data shown below were collected from the profiles of 53 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 329 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 <1%
United Kingdom 1 <1%
Denmark 1 <1%
Unknown 325 99%

Demographic breakdown

Readers by professional status Count As %
Researcher 50 15%
Student > Bachelor 49 15%
Student > Master 46 14%
Student > Ph. D. Student 32 10%
Student > Doctoral Student 23 7%
Other 56 17%
Unknown 73 22%
Readers by discipline Count As %
Medicine and Dentistry 98 30%
Psychology 50 15%
Nursing and Health Professions 28 9%
Pharmacology, Toxicology and Pharmaceutical Science 16 5%
Social Sciences 13 4%
Other 44 13%
Unknown 80 24%

Attention Score in Context

This research output has an Altmetric Attention Score of 108. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 August 2022.
All research outputs
#301,707
of 21,773,265 outputs
Outputs from Cochrane database of systematic reviews
#560
of 12,110 outputs
Outputs of similar age
#3,271
of 226,964 outputs
Outputs of similar age from Cochrane database of systematic reviews
#11
of 239 outputs
Altmetric has tracked 21,773,265 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,110 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 29.5. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 226,964 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 239 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.